Emergent BioSolutions Inc. (EBS) › Gross ProfitEmergent BioSolutions Inc. (EBS) — Gross ProfitAnnual figures by period end, from SEC filings.2020-12-31: $925.20M2021-12-31: $891.30M2022-12-31: $383.00M2023-12-31: $317.60M$317.60M2020-12-31Gross Profit (USD)2023-12-31Period endedGross ProfitChange YoYSource filing2023-12-31$317.60M-17.1%2024-03-08From 2023-01-012022-12-31$383.00M-57.0%2024-03-08From 2022-01-012021-12-31$891.30M-3.7%2024-03-08From 2021-01-012020-12-31$925.20M—2023-12-11From 2020-01-01Other metrics: RevenueCost of RevenueOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per ShareWeighted Average Diluted SharesEPS (Basic)